A 52-year-old man from Delhi presents to the emergency department with a 3-day history of high fever (39.5°C), productive cough with rust-coloured sputum, and pleuritic chest pain. On examination, he is tachypneic (RR 28/min), and auscultation reveals bronchial breath sounds over the left lower lobe. Chest X-ray shows a left lower lobar consolidation. Blood culture and sputum culture are sent. A Gram stain of the sputum shows Gram-positive diplococci. The patient has no prior antibiotic exposure. Which of the following is the most appropriate initial empirical antibiotic therapy for this patient?

Explanation

## Clinical Diagnosis **Key Point:** The clinical presentation—acute lobar pneumonia with rust-coloured sputum, Gram-positive diplococci on Gram stain, and lobar consolidation on CXR—is classic for *Streptococcus pneumoniae* community-acquired pneumonia (CAP). ## Antibiotic Selection in Non-Severe CAP **High-Yield:** In India and most guidelines (IDSA, BTS), for non-severe CAP with suspected pneumococcal etiology and no prior antibiotic exposure, **3rd-generation cephalosporins (ceftriaxone or cefotaxime) are the preferred empirical agents**. They provide excellent lung penetration, cover penicillin-susceptible and many intermediate-resistance strains, and are the standard of care for hospitalized CAP. **Clinical Pearl:** Penicillin G, though historically the gold standard for fully susceptible *S. pneumoniae*, is now reserved for meningitis (higher CSF penetration needed) or for confirmed susceptible isolates. For pneumonia, cephalosporins are preferred because they achieve better lung concentrations and cover a broader spectrum of resistance patterns. ## Why Ceftriaxone Is Correct | Feature | Ceftriaxone | Penicillin G | Vancomycin | Fluoroquinolone | |---------|------------|-------------|-----------|----------------| | Lung penetration | Excellent | Good | Good | Excellent | | Coverage (susceptible + intermediate) | Yes | Susceptible only | Yes | Yes | | Standard empirical CAP | **Yes** | No (reserved for meningitis) | Reserved for severe/resistant | Monotherapy not recommended | | Dosing in CAP | 1–2 g IV 12-hourly | 2 MU IV 4-hourly | 15–20 mg/kg 8–12-hourly | 750 mg daily | **Mnemonic:** **CEPHALOSPORIN for CAP** — Cephalosporins are first-line for Community-Acquired Pneumonia with suspected pneumococcal etiology. ## Why Other Options Are Suboptimal 1. **Penicillin G** — Historically used, but now reserved for meningitis or confirmed fully susceptible strains. Not empirical choice for CAP in modern practice. 2. **Vancomycin** — Reserved for severe sepsis, meningitis, or documented resistance. Overkill for non-severe CAP and increases cost and nephrotoxicity risk. 3. **Fluoroquinolone monotherapy** — Adequate coverage but not recommended as monotherapy for hospitalized CAP; combination therapy or beta-lactam preferred per IDSA guidelines. [cite:Harrison 21e Ch 297]